NCT05432011

Brief Summary

This study aims to analyze the effect of Pericapsular Nerve Group (PENG) Block combined with lateral femoral cutaneous nerve block vs. PENG block combined with wound infiltration for analgesia after elective hip replacement performed with a posters-lateral approach. Half of participants will receive a PENG Block combined with femoral lateral cutaneous nerve block, while the other half will receive PENG Block combined with wound infiltration

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable pain

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 20, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 24, 2022

Completed
7 days until next milestone

Study Start

First participant enrolled

July 1, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 18, 2023

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2023

Completed
Last Updated

August 30, 2023

Status Verified

August 1, 2023

Enrollment Period

11 months

First QC Date

June 20, 2022

Last Update Submit

August 29, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Static Pain Score

    A numerical rating scale (NRS) from 0 (no pain) to 10 (worst imaginable pain) will be used to evaluate pain at rest during 24 hours after surgery

    24 hours

  • Dynamic Pain Score

    A numerical rating scale (NRS) from 0 (no pain) to 10 (worst imaginable pain) will be used to evaluate pain on movement during 24 hours after surgery

    24 hours

Secondary Outcomes (8)

  • Morphine consumption

    24 hours

  • Morphine consumption

    6 days

  • Range of hip motion

    24 hours

  • Quadriceps Strength

    24 hours

  • Ability to start physiotherapy during the first postoperative day

    24 hours

  • +3 more secondary outcomes

Study Arms (2)

PENG block plus Femoral Cutaneous Nerve Block

EXPERIMENTAL

Participants receiving PENG block combined to Lateral Femoral Cutaneous Nerve Block

Procedure: PENG BlockProcedure: Lateral Femoral Cutaneous Nerve Block

PENG block plus Wound Infiltration

ACTIVE COMPARATOR

Participants receiving PENG block combined to wound infiltration

Procedure: PENG BlockProcedure: Wound Infiltration

Interventions

PENG BlockPROCEDURE

At the end of surgery, in Post Anesthesia Recovery Room (PACU), PENG block with 20 mL of 0.5 % Ropivacaine will be executed as described by Giron-Arango et al. using a low frequency curvilinear probe. A 22G 80 mm needle (Stimuplex Ultra 360, B.Braun) will be used.

PENG block plus Femoral Cutaneous Nerve BlockPENG block plus Wound Infiltration

At the end of surgery, in Post Anesthesia Recovery Room (PACU), ultrasound guided Lateral Femoral Cutaneous Nerve Block will be performed with 10 mL of 0.5 % Ropivacaine using a high frequency linear probe. A 22G 50 mm needle (Stimuplex Ultra 360, B.Braun) will be used.

PENG block plus Femoral Cutaneous Nerve Block

At the end of operation, the surgeon will perform wound infiltration with 20 mL of 0.5 % Ropivacaine.

PENG block plus Wound Infiltration

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective hip replacement surgery performed with a poster-lateral approach
  • ASA physical status score \< 4

You may not qualify if:

  • Contraindications to regional anesthesia
  • ASA physical status score ≥ 4
  • Patient's refusal or inability to sign the informed consent
  • Allergies to any drug provided by the study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Campus Bio-medico University Hospital Foundation

Rome, Italy

Location

Related Publications (4)

  • Pascarella G, Costa F, Del Buono R, Pulitano R, Strumia A, Piliego C, De Quattro E, Cataldo R, Agro FE, Carassiti M; collaborators. Impact of the pericapsular nerve group (PENG) block on postoperative analgesia and functional recovery following total hip arthroplasty: a randomised, observer-masked, controlled trial. Anaesthesia. 2021 Nov;76(11):1492-1498. doi: 10.1111/anae.15536. Epub 2021 Jul 1.

  • Aliste J, Layera S, Bravo D, Jara A, Munoz G, Barrientos C, Wulf R, Branez J, Finlayson RJ, Tran Q. Randomized comparison between pericapsular nerve group (PENG) block and suprainguinal fascia iliaca block for total hip arthroplasty. Reg Anesth Pain Med. 2021 Oct;46(10):874-878. doi: 10.1136/rapm-2021-102997. Epub 2021 Jul 20.

  • Giron-Arango L, Peng PWH, Chin KJ, Brull R, Perlas A. Pericapsular Nerve Group (PENG) Block for Hip Fracture. Reg Anesth Pain Med. 2018 Nov;43(8):859-863. doi: 10.1097/AAP.0000000000000847.

  • Del Buono R, Padua E, Pascarella G, Costa F, Tognu A, Terranova G, Greco F, Fajardo Perez M, Barbara E. Pericapsular nerve group block: an overview. Minerva Anestesiol. 2021 Apr;87(4):458-466. doi: 10.23736/S0375-9393.20.14798-9. Epub 2021 Jan 12.

MeSH Terms

Conditions

PainPain, PostoperativeAcute PainAgnosiaPostoperative Complications

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic ProcessesPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Study Officials

  • Giuseppe Pascarella, MD

    University Hospital Campus Biomedico of Rome

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 20, 2022

First Posted

June 24, 2022

Study Start

July 1, 2022

Primary Completion

May 18, 2023

Study Completion

May 25, 2023

Last Updated

August 30, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations